Primary Total Elbow Arthroplasty With the Coonrad–Morrey Prosthesis in a Chinese Cohort: A Follow‐Up of 5–10 Years
Orthopaedic Surgery · 2026-04 · 18 (4) · 685-694
DOI: 10.1111/os.70276 ↗Kurz gefasst
Fachartikel in der Zeitschrift Orthopaedic Surgery, online erschienen am 12.03.2026. Verfasst von Jianyu Zhang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Peking University Fourth School of Clinical Medicine, Beijing Jishuitan Hospital, Beijing, China. Hauptthemen laut MEDLINE: Arthroplasty, Replacement, Elbow, Elbow Prosthesis, Arthritis, Rheumatoid, Elbow Joint. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Beijing Natural Science Foundation, Beijing Association for Science and Technology, Beijing Jishuitan Hospital Research Fund.
Abstract (Originalsprache)
Objective
Total elbow arthroplasty (TEA) is a commonly performed surgical technique for the management of elbow disorders. The Coonrad–Morrey (CM) prosthesis is the most commonly used prosthesis in TEA. The study from Chinese cohorts remains limited, particularly regarding differences between patients with and without RA. Therefore, the purpose of this study was to evaluate the medium‐ to long‐term clinical outcomes using the CM prosthesis in a Chinese cohort, and to compare clinical outcomes between patients with and without RA.
Methods
A retrospective cohort study was conducted involving 74 patients (75 elbows) who underwent TEA using CM prostheses between March 2015 and February 2019. All patients were followed up for a minimum of 5 years (mean follow‐up: 83.4 months) and were assessed for elbow range of motion (ROM), Mayo Elbow Performance Score (MEPS), Quick‐Disabilities of the Arm, Shoulder and Hand (Quick‐DASH) score, pain, complications, and revision surgeries. Kaplan–Meier survivorship analysis was conducted. The differences between patients with and without rheumatoid arthritis (RA) were compared in the subgroup analysis.
Results
At the final follow‐up, the average flexion‐extension ROM was 105.3° ± 33.6°. The mean MEPS was 85.5 ± 14.3, with a good‐to‐excellent rate of 81.3%. The mean Quick‐DASH score was 30.8 ± 18.1. A total of 26 complications (26/75, 34.7%) were observed in 22 elbows (22/75, 29.3%). Nine elbows (9/75, 12.0%) underwent reoperation. The revision‐free rates were 98.7% at 1 year, 94.7% at 2 years, and 90.7% at 5 years. There were no significant differences in elbow function or revision‐free rate between patients with and without RA.
Conclusion
TEA using CM prosthesis in Chinese patients can achieve favorable functional outcomes regardless of RA status, with a high 5‐year prosthesis survival rate. However, a larger sample size and a longer follow‐up period are still required.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Peking University Fourth School of Clinical Medicine, Beijing Jishuitan Hospital, Beijing, China.
- Department of Orthopedic Trauma, Beijing Jishuitan Hospital, Capital Medical University, Beijing, China.
ORCID-Profile: Yejun Zha
Förderung
- Beijing Natural Science Foundation
- Beijing Association for Science and Technology
- Beijing Jishuitan Hospital Research Fund
- Natural Science Foundation of Beijing Municipality
Zitieren
APA
Zhang, J., Hua, K., Xiao, D., Chen, C., Gong, M., Zha, Y., & Jiang, X. (2026). Primary Total Elbow Arthroplasty With the Coonrad–Morrey Prosthesis in a Chinese Cohort: A Follow‐Up of 5–10 Years. Orthopaedic Surgery, 18(4), 685-694. https://doi.org/10.1111/os.70276
Vancouver
Zhang J, Hua K, Xiao D, Chen C, Gong M, Zha Y, et al. Primary Total Elbow Arthroplasty With the Coonrad–Morrey Prosthesis in a Chinese Cohort: A Follow‐Up of 5–10 Years. Orthopaedic Surgery. 2026;18(4):685-694. doi:10.1111/os.70276
BibTeX
@article{Zhang2026,
author = {Zhang, Jianyu and Hua, Kehan and Xiao, Dan and Chen, Chen and Gong, Maoqi and Zha, Yejun and Jiang, Xieyuan},
title = {Primary Total Elbow Arthroplasty With the Coonrad–Morrey Prosthesis in a Chinese Cohort: A Follow‐Up of 5–10 Years},
journal = {Orthopaedic Surgery},
year = {2026},
volume = {18},
number = {4},
pages = {685--694},
doi = {10.1111/os.70276}
}
EUVIMED